Skip to main content


Plotting Future ACR Convergence Meetings (11.24.2023)

Nov 24, 2023

In this week's podcast, Dr. Jack Cush reviews the ACR Convergence 2023 meeting and proposes how to best learn at your next large medical meeting.

Read Article

Rheumatology Roundup - ACR 2023

Nov 17, 2023

Drs. Jack Cush and Arthur Kavanaugh discuss highlights and key takeaways from ACR 23.

Read Article
All of us need to remind each other to take care of yourself! Some tips from Dr. Whitney Marvin - exercise, date night, talking to a friend - take breaks, mindfulness - eating away from computer (as I type this on my desk, next to my lunch) @RheumNow #ACR23
Nov 14, 2023

Day 2 Report - ACR Plenaries: Changing the Practice of Rheumatology

Nov 14, 2023

Over the years of navigating the annual meeting, I found the sessions with the most impact to my practice were the Plenary Sessions. During these sessions, the latest research is presented, new ideas are floated, and old myths debunked. Here are the top ACR2023 Plenary abstracts I found

Read Article
#ACR23 Memorable Quote as reminded to us by Dr. P Seo during Year in Review: "What you think of as a rare manifestation of a common disease is probably a common presentation of a disease you are not aware of (yet)!" - Prof Seza Zen, MD @RheumNow

ACR Reacts to 2024 Medicare Physician Fee Schedule

Nov 06, 2023

The American College of Rheumatology (ACR) expressed concern that the conversion factor included in the Centers for Medicare and Medicaid Services (CMS) CY 2024 Medicare Physician Fee Schedule and Quality Payment Program final rule is insufficient to address rising inflation. However, ACR is

Read Article

Optimal Management of de Quervain Tenosynovitis

Nov 01, 2023

The treatment of de Quervain tenosynovitis (DQT) was examined  by systematic review in JAMA, suggesting that local (US-guided) corticosteroid injection plus a thumb spica immobilization was associated with significant pain-relieving and functional benefits. 

Read Article

Sleep Apnea Smart Watches (10.13.2023)

Oct 13, 2023

Dr. Jack Cush reviews the news, journal reports and regulatory approvals from this past week on

  1. Full Read review of #PMR in Lancet: - Start @ 12·5–25mg prednisone qd - Remission in most but, relapses in 40–60% - Onset sudden; AM stiffness predominates;

Read Article

TNR: PMR Diagnosis and Monitoring

Oct 04, 2023

Panelists Dr. Claire Owen, Stephen Paget, Anisha Dua and Jack Cush discuss diagnosis and monitoring in PMR during this week's Tuesday Night Rheumatology.

Read Article

RheumNow Podcast with Special Guest Dr. Michael Weinblatt (9.22.2023)

Sep 22, 2023

Dr. Jack Cush is joined by Dr. Michael Weinblatt as they discuss this weeks news and journal reports, including difficult RA, HLA typing and abatacept responses and new regulatory decisions. 

  1. UCB has issued a press update on its pending application for the approval of their

Read Article

RheumNow Podcast – with Special Guest Dr. Janet Pope (9.8.2023)

Sep 08, 2023

This week, Dr. Jack Cush reviews the news with special guest, Dr. Janet Pope. They discuss "Not-non-Inferior", large scale genetic screening, Zoster risk w/ newer lupus drugs, tapering, RA referral problems and the TNR webinar session on "ORAL Surveillance Revisited".

Read Article

Woeful Rheumatology Referrals

Sep 07, 2023

Early diagnosis of inflammatory arthritis (IA) is rooted in patient (self or MD) referrals. A recent analysis shows only a minority of rheumatology referrals had inflammatory arthritis, with only 21% were seen within the first 6 weeks of symptoms. 

A total of 1023 were patients

Read Article

Dr. Naomi Rothfield (1929 – 2023)

Aug 29, 2023

Medical schools are rife with mentors. In my rheumatology fellowship I had tow great mentors, Peter Lipsky and Morris Ziff.  They introduced me, and other young rheumatologists, to other rheumatology giants and mentors, including Dr. Naomi Rothfield - who they often spoke of as a leader worth

Read Article

WSJ: Do Younger or Older Doctors Get Better Results?

Aug 23, 2023

A recent Wall St. Journal essay (by AB Jena and C Worsham) suggests that a physician’s effectiveness has less to do with age than with how many patients they see and how well they stay up to date on research.

If admitted to the hospital would you rather your physician be in their 50s

Read Article

Patient Perspectives on Telemedicine Use During the Pandemic

Aug 08, 2023

Research from the COVID-19 Global Rheumatology Alliance included surveys and data gathering from rheumatology patients. During the pandemic era there was rapid adoption of telemedicine by rheumatologists; and a recent study of patient perspectives shows that most found telemedicine to be at

Read Article

Rheumatology Journals Rife With Faulty Conflict-of-Interest

MedPage Today
Aug 03, 2023

More often than not, conflict-of-interest disclosures in three major rheumatology journals didn't match records in the U.S. government's Open Payments database, researchers found.

About two-thirds of a random selection of recent papers in these journals included authors who had

Read Article

Dr. Joseph Flood (1952-2023) - Past ACR President

Jul 24, 2023

Dr Joseph Flood, a past president of the American College of Rheumatology, passed away on July 13, 2023 at age 70 due to complications of liver disease, diabetes and liver cancer.

He was born in Cleveland, schooled at St Ignatius High School in Cleveland and graduated college Baldwin-

Read Article

ICYMI: ChatGPT - A Boon or Threat to Scientific Publication?

Jul 07, 2023

ChatGPT is a new, artificial intelligence chatbot that has dramatically changed the digital worlds of education, research, graphic design, statistics and more. While this AI driven platform has the untold potential in generating written content, there is considerable concern in assuring that 

Read Article

ICYMI: 25 Great Women in Rheumatology

Jul 04, 2023

I reached out to many leaders in rheumatology and asked: who are the great women in rheumatology who should be recognized? This was prompted by a smart article in Annals of Rheumatic Disease written by Drs. Tuhina Neogi (Boston) and Nicola Dalbeth (N. Zealand), entitled "Where are the women ‘

Read Article

Dr. K. Frank Austen (1928-2023)

Jun 29, 2023

Rheumatology mourns the loss of a historic leader in the field, Dr. K. Frank Austen, who died at his home in Maine on June 23, 2023, at the age of 95.

For six decades Dr. Austen was an influential leader, researcher and mentor to scores of many influential physician-scientists in

Read Article

Scary Outcomes with Systemic Sclerosis Sine Scleroderma

Jun 29, 2023

The hallmark of systemic sclerosis is scleroderma, but less than 10% of SSc patients have sine scleroderma (ssSSc). A EUSTAR database review compared the manifestations and outcomes of ssSSC to limited cutaneous SSc and diffuse cutaneous SSc.

Read Article

Why Patients Don't Take Medicines

Jun 22, 2023

About 60% of adults aged 18 and over reported taking at least one prescription medication in 2021, with 36% reporting taking three or more. Out-of-pocket costs on retail drugs rose 4.8% to $63 billion in 2021. High costs may limit individuals’ access to medications and lead to people not

Read Article

Are bDMARDs, tsDMARDs and biosimilar DMARDs cost effective?

Jun 20, 2023

Treatment advances with new biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) have proven efficacy and safety; but does their increased cost yield commensurate benefits in patients with rheumatoid arthritis (RA) and

Read Article

ACR Concerned with MedPAC’s Cutting Part B Reimbursement

Jun 15, 2023

The American College of Rheumatology (ACR) today expressed disappointment that the Medicare Payment Advisory Commission (MedPAC) has recommended yet another cut to physician reimbursement for infusing life-altering treatments as part of its June 2023 Report to the Congress: Medicare and the

Read Article

Why Depression Screening Should be Mandatory at Each Visit

Jun 14, 2023

Depression is more widespread than ever in the United States, according to a new study from Gallup, showing that 18% of adults are depressed (or receiving depression treatment for depression) – an increase in 7 percentage points since 2015. 

Read Article